First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - eClinicalMedicine
DStv Premiership Starting XI: TS Galaxy v Kaizer Chiefs 05 June 2021
Evaluation of the BH3-only Protein Puma as a Direct Bak Activator* - Journal of Biological Chemistry
Page 2 - Allgemeine Ss High Resolution Stock Photography and Images - Alamy